Last reviewed · How we verify
NCT07542288
Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases:
Phase 2, PHASE3 trial testing Methylprednisolone (Corticosteroid) in Brain Metastases From Solid Tumors in 400 participants. Not yet recruiting.
Quick facts
| Lead sponsor | The Second Affiliated Hospital of Hainan Medical University |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Not yet recruiting |
| Enrollment | 400 |
| Start date | 15 April 2026 |
| Estimated completion | 30 June 2028 |
Drugs / interventions tested
- Methylprednisolone (Corticosteroid) — full drug profile →
- Dexamethasone (dexamethasone) — full drug profile →
Conditions studied
- Brain Metastases From Solid Tumors — all drugs for Brain Metastases From Solid Tumors →
Sponsor
The Second Affiliated Hospital of Hainan Medical University
Who can join
Eligibility, any sex, with Brain Metastases From Solid Tumors.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07542288
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Methylprednisolone (Corticosteroid)
Trials testing the same drug.
- NCT07208799 — Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures · Phase 2 · recruiting
- NCT07270549 — Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome · Phase 1, PHASE2 · recruiting
- NCT07077486 — Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease · Phase 4 · recruiting
- NCT06762145 — EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial) · Phase 4 · not yet recruiting
- NCT06932367 — The Efficacy of Dexketoprofen And Methylprednisolone in the Acute Low Back Pain · Phase 4 · completed
Other recruiting trials for Brain Metastases From Solid Tumors
Currently open trials in the same condition.
- NCT06136884 — A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Br · Phase 1 · recruiting
Other The Second Affiliated Hospital of Hainan Medical University trials
Trials by the same sponsor.
- NCT06796270 — Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma · NA · recruiting
- NCT06905561 — Topical Diclofenac for Prevention of Radiation-induced Dermatitis · NA · recruiting
- NCT06531681 — Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac) · recruiting
- NCT06095570 — The Study of Ciprofol for the Suppression of Cardiovascular Responses to Tracheal Intubation · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07542288 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Second Affiliated Hospital of Hainan Medical University
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07542288.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing